NCT01283399 An Observational Study of Rituximab in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT01283386 A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Participants With Chronic Lymphocytic Leukemia and Unfavorable Somatic Status Status TERMINATED Phase PHASE4
NCT01283074 An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HbeAg-negative Chronic Hepatitis B (Perseas) Status COMPLETED Phase N/A
NCT01280656 A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION) Status COMPLETED Phase N/A
NCT01278134 A Study of RO5024048 in Combination With Ritonavir-Boosted Danoprevir With or Without Copegus (Ribavirin) in Interferon-Naïve Patients With Chronic Hepatitis C Genotype 1 (INFORM-SVR) Status COMPLETED Phase PHASE2
NCT01277328 An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Status TERMINATED Phase N/A
NCT01277133 An Observational Study on The Correlation Between Time of Initiation of Avastin (Bevacizumab) Treatment And Progression-Free Survival in Patients With Metastatic Breast Cancer (CRONOS 2) Status TERMINATED Phase N/A
NCT01277120 An Observational Study on The Correlation Between Time of Initiation of Avastin (Bevacizumab) Treatment And Progression-Free Survival in Patients With Colorectal Cancer (CRONOS 1) Status TERMINATED Phase N/A
NCT01277094 A Study of RO5093151 in Patients With Non-Alcoholic Fatty Liver Disease Status COMPLETED Phase PHASE1
NCT01276405 An Observational Study of Xeloda (Capecitabine) Monotherapy in Patients With Colorectal Cancer (AXEL) Status TERMINATED Phase N/A
NCT01272908 A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior Anti-TNF Therapy (RESET) Status COMPLETED Phase PHASE3
NCT01271803 A Study of Vemurafenib and GDC-0973 (Cobimetinib) in Participants With BRAFV600E Mutation-Positive Metastatic Melanoma Status COMPLETED Phase PHASE1
NCT01271010 A Study of Rituximab in Combination With Fludarabine and Cyclophosphamide in Participants With Chronic Lymphocytic Leukemia and Favorable Somatic Status Status TERMINATED Phase PHASE4
NCT01268033 Efficacy of Rituximab For the Treatment of Calcineurin Inhibitors Dependent Nephrotic Syndrome During Childhood Status COMPLETED Phase PHASE2/PHASE3
NCT01266564 An Observational Study of Avastin (Bevacizumab) in Patients With Colorectal Cancer Status COMPLETED Phase N/A
NCT01264380 A Study of the Effect of Food on the Pharmacokinetics of Single Dose RO5185426 And the Safety And Efficacy of Continuous Administration in Patients With BRAF V600E Mutation-Positive Metastatic Melanoma Status COMPLETED Phase PHASE1
NCT01263704 A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT01260194 A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancer Status TERMINATED Phase PHASE4
NCT01260181 A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations Status COMPLETED Phase PHASE2
NCT01258101 A Study of PEGASYS (Peginterferon Alfa-2a) Plus Ribavirin in Patients With Chronic Hepatitis C (CHC), Genotype 2 or 3 Status COMPLETED Phase PHASE4